New study aims to sharpen prostate cancer detection

NCT ID NCT07306741

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two prostate biopsy techniques—cognitive-targeted and MRI-ultrasound fusion—to see which detects prostate cancer more accurately. About 80 men with elevated PSA and suspicious MRI findings will participate. Results may help doctors choose the best biopsy method for diagnosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Menoufia university hospital urology department

    NOT_YET_RECRUITING

    Shibīn al Kawm, Egypt

  • Menoufia university hospital urology department

    RECRUITING

    Shibīn al Kawm, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••